Regeneron Pharmaceuticals has acquired 23andMe – and the genetic data for 15 million customers along with it. Credit: Tiffany Hagler-Geard/Bloomberg via Getty Images 23andMe had all the signs of a ...

PALO ALTO, Calif. and SAN FRANCISCO, May 20, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical ...

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the SEC. The company filed for for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals ...

The sale of 23andMe was finalized this week, following the company filing for bankruptcy in March. The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research ...

The deadline to submit a claim form for a 23andMe settlement is fast approaching. Millions of customers are expected to receive payouts from a $50 million settlement over a 23andMe customer data ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Abigail Adams is a Human Interest Writer-Reporter for PEOPLE. Justin Sullivan/Getty; Michael Nagle ...

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...